Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

photo_charlie_richard

Oxyrane brings on board senior team

January 30, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Oxyrane, biotech

UK biotech firm Oxyrane has expanded to the US and made a number of senior appointments. The privately-owned Manchester-based company’s first …

Appointment

Parexel’s BioPharm Unit to aid smaller R&D firms

July 25, 2012
Research and Development Parexel, R&D, biotech

Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …

News

Significant reorganisation for Chelsea Therapeutics

July 11, 2012
Research and Development, Sales and Marketing Chelsea Therapeutics, Northera, biopharma, biotech

Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …

News

British biotech industry gains £200m boost

March 21, 2012
Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund

The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …

News

Moving towards milestones: the evolving pharma – biotech relationship

January 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deals, Susan Aldridge, biotech, pharma

Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …

Feature
GlaxoSmithKline

GSK invests in UK biotech start-up

August 22, 2011
Research and Development Autifony, GSK, biotech, hearing loss, research and development news

GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …

News

BMS makes $325m biotech acquisition

July 25, 2011
Research and Development, Sales and Marketing BMS, biotech, research and development news

Bristol-Myers Squibb is to plug gaps in its pipeline by buying private biotech company Amira Pharmaceuticals for $325 million in …

News

Actelion plans biotech start-up

June 20, 2011
Research and Development Actelion, biotech

Swiss biopharmaceutical company Actelion is planning to launch a biotech start-up that would run separately from the main company. It …

News

Promoting UK biotech’s voice and mission

June 8, 2011
Research and Development ERBI, One Nucleus, biotech

One Nucleus is a new organisation formed from the merger of two of England’s regional networks – ERBI (Eastern Region …

Feature

British biotech: rebuilding momentum

May 26, 2011
Research and Development UK, biotech, biotech funding

Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …

Feature

Circassia raises funds to develop allergy products

April 19, 2011
Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …

News

TcL Pharma appoints French pharma veterans

April 1, 2011
Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment

TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …

News

Biotech lobbies for further UK tax breaks

March 17, 2011
Research and Development BIA, R&D tax credits, biotech

Biotech companies are calling on Chancellor George Osborne to provide extra incentives for research in his forthcoming Budget. The budget …

News

Scottish biotech ProStrakan sold for £292m

February 22, 2011
Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech

Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …

News

Trial failures threaten UK biotech

February 18, 2011
Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech

A number of late stage failures from British biotech firms have left a looming question mark over the future of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025